Hypoglycemia and Quality Measurement Sam Stolpe PQA Senior Director - - PDF document

hypoglycemia and quality measurement
SMART_READER_LITE
LIVE PREVIEW

Hypoglycemia and Quality Measurement Sam Stolpe PQA Senior Director - - PDF document

Hypoglycemia and Quality Measurement Sam Stolpe PQA Senior Director PQA The Triple Aim Affordable Affordable Better Better Care Care Care Care Healthy People/ Healthy People/ Communities Communities PQA PQA PQA PQA 1


slide-1
SLIDE 1

PQA 1

Hypoglycemia and Quality Measurement

Sam Stolpe PQA Senior Director

PQA

The Triple Aim

Better Care Better Care Affordable Care Affordable Care

PQA PQA

Healthy People/ Communities Healthy People/ Communities

PQA

slide-2
SLIDE 2

PQA 2 Comprehensive Overview of CMS Quality Programs

Hospital Quality Physician Quality PAC Quality Payment Models Population Health

  • Meaningful use

EHR incentive

  • Inpatient quality
  • Meaningful use

EHR incentive

  • Physician Quality
  • Inpatient

rehabilitation facility

  • Medicare Shared

Savings Program (ACOs)

  • Medicare Part C
  • Medicare Part D

M di id Ad lt p q y reporting

  • Outpatient

quality reporting

  • Ambulatory

surgical centers

  • Readmission

reduction program HAC t y y Reporting System (PQRS)

  • Value-based

Payment Modifier (VM)

  • Maintenance of

certification

  • Nursing Home

Compare measures

  • LTCH quality

reporting

  • Hospice quality

reporting

  • Home health

quality reporting

  • Hospital value-

based purchasing

  • Physician

Feedback

  • ESRD QIP
  • Innovations

Pilots

  • Medicaid Adult

Core Measures

  • Medicaid Child

Core Measures

  • Health Insurance

Exchange Quality Reporting System (QRS)

PQA PQA

  • HAC payment

reduction program

  • PPS-exempt

cancer hospitals

  • Inpatient

psychiatric facilities qua y epo g

Hypoglycemia Contribution to Health Burden

  • Ambulatory Patients

Insulin 1st most common drug implicated in ED visits for

  • Insulin 1st most common drug implicated in ED visits for

ADEs overall (~8%)1

  • Insulin and oral diabetes drug implicated in ~25% of

emergent hospitalizations for ADEs in older adults2

  • Hospitalized Patients

Hypoglycemia was 3rd most common ADE3

PQA PQA

  • Hypoglycemia was 3rd most common ADE3
  • Skilled Nursing Facility Patients
  • Hypoglycemia was 1st most common ADE4
  • 1. JAMA. 2006;296:1858-1866 2. N Engl J Med. 2011;365:2002-2012
  • 3. Adverse Events in Hospitals, 2010, OEI-06-09-00090
  • 4. Adverse Events in Skilled Nursing Facilities, 2014, OEI-06-11-00370
slide-3
SLIDE 3

PQA 3 National Adverse Drug Event Action Plan

Three key focus areas

  • Hypoglycemia-inducing medications
  • Anticoagulation medications
  • Opioids

PQA PQA

National Adverse Drug Event Action Plan

Four key strategies

  • Surveillance
  • Evidence-based prevention tools
  • Incentives and Oversight

PQA PQA

  • Research
slide-4
SLIDE 4

PQA 4 National Adverse Drug Event Action Plan

Four key strategies

  • Surveillance
  • Evidence-based prevention tools
  • Incentives and Oversight

PQA PQA

  • Research

National Focus on Hypoglycemia Measures

  • Update measures
  • Individualize hypoglycemic risk targets, comorbidities

yp g y g ,

  • Coordinated models of care (esp. inpatient)
  • Most recent science
  • ER/Hospitalizations from ambulatory care, community
  • Address payment barriers to uptake of evidence-based, high-quality

ADE prevention strategies

  • E.g., use of patient engagement and health literacy principles.

PQA PQA

  • Improve EHR standards to identify high risk patients
  • Transitions of Care/Coordinated Care
  • 2/3 of post-discharge complications are from ADEs1
  • 1. Forster AJ et al. Ann Intern Med 2003;138:161–7.
slide-5
SLIDE 5

PQA 5 Current Measure Examples

  • Community setting
  • PQA Diabetes Dosing Measure

g

  • The percentage of patients who were dispensed a dose higher than the daily

recommended dose for the following therapeutic categories of oral hypoglycemics: biguanides, sulfonlyureas, thiazolidinediones and DPP-IV inhibitors.

  • Currently included inside CMS Part C & D Display Measures
  • Inpatient setting
  • NQF 2363: Glycemic Control – Severe Hypoglycemia
  • Patients administered short acting insulin within 12 hours or other DM agent within 24

PQA PQA

Patients administered short acting insulin within 12 hours or other DM agent within 24 hours

  • Suitable for inclusion inside of the Hospital Inpatient Quality Reporting System

DDM 5-Year Plan Average Performance

1.71% 1 80%

PDP & MA-PD Measure Performance

1.71% 1.33% 1.13% 0.89% 0.74% 0.60% 0.80% 1.00% 1.20% 1.40% 1.60% 1.80% PQA PQA 0.00% 0.20% 0.40% 2011 2012 2013 2014 2015

Source: CMS Part C & D Display Measure Data

slide-6
SLIDE 6

PQA 6 New PQA Measure Concept

  • Serious Hypoglycemic Events Requiring Hospital Admission or ED

Visit Associated with Anti-Diabetic Medications

  • The rate of events among individuals receiving anti-diabetes medications that
  • have evidence of a hospitalization or emergency department visit related to a

hypoglycemic event

  • expressed as number of events per member-months.
  • This measure is used among plans with both prescription and medical

claims/services, and a lower value is indicative of higher quality

  • Currently undergoing measure testing

PQA PQA

y g g g

Contact info: Questions?

Sam Stolpe SStolpe@PQAalliance.org 703-470-4741

PQA PQA PQA